Bayer AG (WAR:BAY) Total Liabilities: zł347,557 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:BAY Bayer AG WAR:BAY
45 GF Score
Price zł217.80
GF Value zł115.76
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Bayer AG Total Liabilities?

Bayer AG WAR:BAY 45 Total Liabilities is zł347,557 Mil as of Mar. 2026. GuruFocus rates WAR:BAY with a GF Score™ of 45/100 and a GF Value™ of zł115.76 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Bayer AG's Total Liabilities for the quarter that ended in Mar. 2026 was zł347,557 Mil.

Bayer AG's quarterly Total Liabilities increased from Sep. 2025 (zł332,876.92 Mil) to Dec. 2025 (zł349,787.75 Mil) but then declined from Dec. 2025 (zł349,787.75 Mil) to Mar. 2026 (zł347,557.42 Mil).

Bayer AG's annual Total Liabilities declined from Dec. 2023 (zł345,278.34 Mil) to Dec. 2024 (zł314,097.83 Mil) but then increased from Dec. 2024 (zł314,097.83 Mil) to Dec. 2025 (zł349,787.75 Mil).

Bayer AG Total Liabilities Historical Data

* Premium members only.

The historical data trend for Bayer AG's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG Total Liabilities Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 374,502.55 346,572.01 345,278.34 314,097.83 349,787.75

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 315,215.27 328,114.40 332,876.92 349,787.75 347,557.42
WAR:BAY
45GF Score
Bayer AG WAR:BAY
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bayer AG's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=145236.038+(141763.923+47941.042
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+10131.088+4715.658)
=349,788

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=465954.294-116166.545
=349,788

Bayer AG's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=147239.512+(0+185901.984
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+9425.793+4715.658)
=347,557

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=475003.641-127446.226
=347,557

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of zł347,557 Mil mean?
Bayer AG (WAR:BAY) has a Total Liabilities of zł347,557 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bayer AG and its competitors.
Is Bayer AG's Total Liabilities too high?
Bayer AG's current Total Liabilities is zł347,557 Mil. Overall, Bayer AG has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's Total Liabilities compare to LLY and JNJ?
Bayer AG's Total Liabilities of zł347,557 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Bayer AG and its competitors. Bayer AG's current Total Liabilities is zł347,557 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (WAR:BAY) is currently considered Significantly Overvalued. The stock's GF Value™ is zł115.76, compared to a current price of zł217.80 — trading 88.1% above its estimated fair value. The current Total Liabilities is zł347,557 Mil. Bayer AG's overall GF Score™ is 45/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Bayer AG (WAR:BAY), the current Total Liabilities is zł347,557 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł217.80 is trading 88.1% above its estimated GF Value™ of zł115.76. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • Total Liabilities: zł347,557 Mil
  • GF Value™: zł115.76 vs. price of zł217.80 (88.1% above fair value)
  • GF Score™: 45/100 with 7 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
45GF Score

Get the complete analysis for WAR:BAY

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł217.80
Price
zł115.76
GF Value